Journal Article
. 2014 Dec;33(4).
doi: 10.1200/JCO.2014.55.3107.

Receipt of chemotherapy among medicare patients with cancer by type of supplemental insurance

Joan L Warren 1 Eboneé N Butler 2 Jennifer Stevens 2 Christopher S Lathan 2 Anne-Michelle Noone 2 Kevin C Ward 2 Linda C Harlan 2 
Affiliations
  • PMID: 25534387
  •     16 References
  •     14 citations

Abstract

Purpose: Medicare beneficiaries with cancer bear a greater portion of their health care costs, because cancer treatment costs have increased. Beneficiaries have supplemental insurance to reduce out-of-pocket costs; those without supplemental insurance may face barriers to care. This study examines the association between type of supplemental insurance coverage and receipt of chemotherapy among Medicare patients with cancer who, per National Comprehensive Cancer Network treatment guidelines, should generally receive chemotherapy.

Patients And Methods: This retrospective, observational study included 1,200 Medicare patients diagnosed with incident cancer of the breast (stage IIB to III), colon (stage III), rectum (stage II to III), lung (stage II to IV), or ovary (stage II to IV) from 2000 to 2005. Using the National Cancer Institute Patterns of Care Studies and linked SEER-Medicare data, we determined each Medicare patient's supplemental insurance status (private insurance, dual eligible [ie, Medicare with Medicaid], or no supplemental insurance), consultation with an oncologist, and receipt of chemotherapy. Using adjusted logistic regression, we evaluated the association of type of supplemental insurance with oncologist consultation and receipt of chemotherapy.

Results: Dual-eligible patients were significantly less likely to receive chemotherapy than were Medicare patients with private insurance. Patients with Medicare only who saw an oncologist had comparable rates of chemotherapy compared with Medicare patients with private insurance.

Conclusion: Dual-eligible Medicare beneficiaries received recommended cancer chemotherapy less frequently than other Medicare beneficiaries. With the increasing number of Medicaid patients under the Affordable Care Act, there will be a need for patient navigators and sufficient physician reimbursement so that low-income patients with cancer will have access to oncologists and needed treatment.

Patient out-of-pocket payments for oral oncolytics: results from a 2009 US claims data analysis.
Martin L Raborn, Elise M Pelletier, Daniel B Smith, Carolina M Reyes.
Am J Manag Care, 2012 Jun 22; 18(5 Spec No. 2). PMID: 22693982
The utility of the state buy-in variable in the Medicare denominator file to identify dually eligible Medicare-Medicaid beneficiaries: a validation study.
Siran M Koroukian, Bassam Dahman, Glenn Copeland, Cathy J Bradley.
Health Serv Res, 2009 Oct 21; 45(1). PMID: 19840136    Free PMC article.
Insurance status and the use of guideline therapy in the treatment of selected cancers.
Linda C Harlan, Amanda L Greene, +3 authors, Martin L Brown.
J Clin Oncol, 2005 Nov 23; 23(36). PMID: 16301598
Who does not receive treatment for cancer?
Marcia M Ward, Fred Ullrich, +5 authors, Charles F Lynch.
J Oncol Pract, 2013 May 02; 9(1). PMID: 23633967    Free PMC article.
Inadequate access to surgeons: reason for disparate cancer care?
Cathy J Bradley, Bassam Dahman, Charles W Given.
Med Care, 2009 Jun 19; 47(7). PMID: 19536001
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.
Joan L Warren, Carrie N Klabunde, +2 authors, Gerald F Riley.
Med Care, 2002 Aug 21; 40(8 Suppl). PMID: 12187163
Highly Cited.
Evaluation of trends in the cost of initial cancer treatment.
Joan L Warren, K Robin Yabroff, +3 authors, Martin L Brown.
J Natl Cancer Inst, 2008 Jun 12; 100(12). PMID: 18544740    Free PMC article.
Highly Cited.
Trends in out-of-pocket healthcare costs among older community-dwelling Medicare beneficiaries.
Gerald F Riley.
Am J Manag Care, 2008 Oct 08; 14(10). PMID: 18837647
Predictive margins with survey data.
B I Graubard, E L Korn.
Biometrics, 2001 Apr 25; 55(2). PMID: 11318229
Highly Cited.
Future supply and demand for oncologists : challenges to assuring access to oncology services.
Clese Erikson, Edward Salsberg, +2 authors, Michael Goldstein.
J Oncol Pract, 2007 Mar 01; 3(2). PMID: 20859376    Free PMC article.
Highly Cited.
Disparities in the utilization of high-volume hospitals for complex surgery.
Jerome H Liu, David S Zingmond, +4 authors, Clifford Y Ko.
JAMA, 2006 Oct 26; 296(16). PMID: 17062860
Highly Cited.
The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida.
Lisa C Richardson, Lili Tian, +4 authors, Jill Mackinnon.
Am J Public Health, 2005 Dec 01; 96(1). PMID: 16317209    Free PMC article.
Use and spending on antineoplastic therapy for Medicare beneficiaries with cancer.
Amy J Davidoff, Thomas Shaffer, +6 authors, Rahul Shenolikar.
Med Care, 2012 Dec 12; 51(4). PMID: 23222498
Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer.
Amy J Davidoff, Mujde Erten, +6 authors, Bruce Stuart.
Cancer, 2012 Dec 12; 119(6). PMID: 23225522
Ability of Medicare claims data to identify nursing home patients: a validation study.
Siran M Koroukian, Fang Xu, Patrick Murray.
Med Care, 2008 Oct 28; 46(11). PMID: 18953230    Free PMC article.
Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States.
Joan L Warren, Linda C Harlan, +2 authors, Gregory A Abel.
J Clin Oncol, 2013 Apr 10; 31(16). PMID: 23569317    Free PMC article.
Colon cancer care and survival: income and insurance are more predictive in the USA, community primary care physician supply more so in Canada.
Kevin M Gorey, Sindu M Kanjeekal, +6 authors, Nancy L Richter.
Int J Equity Health, 2015 Oct 30; 14. PMID: 26511360    Free PMC article.
Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States.
Zhiyuan Zheng, K Robin Yabroff, +5 authors, Ahmedin Jemal.
J Natl Cancer Inst, 2015 Dec 26; 108(5). PMID: 26705361    Free PMC article.
Underutilization of gene expression profiling for early-stage breast cancer in California.
Rosemary D Cress, Yingjia S Chen, +2 authors, Kenneth W Kizer.
Cancer Causes Control, 2016 Apr 22; 27(6). PMID: 27097910    Free PMC article.
Survival Gains from First-Line Systemic Therapy in Metastatic Non-Small Cell Lung Cancer in the U.S., 1990-2015: Progress and Opportunities.
Joshua A Roth, Bernardo H L Goulart, +2 authors, Scott D Ramsey.
Oncologist, 2017 Mar 01; 22(3). PMID: 28242792    Free PMC article.
Metastatic Melanoma: Treatment and Survival in the US after the Introduction of Ipilimumab and Vemurafenib.
Lindsey Enewold, Elad Sharon, Linda C Harlan.
Oncol Res Treat, 2017 Apr 05; 40(4). PMID: 28376479    Free PMC article.
Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
Hui Zhao, Ning Zhang, +8 authors, Sharon H Giordano.
Cancer, 2017 Nov 16; 124(4). PMID: 29140558    Free PMC article.
Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.
Yuhua Bao, Renee C Maciejewski, +3 authors, Holly G Prigerson.
J Pain Symptom Manage, 2017 Dec 16; 55(4). PMID: 29241809    Free PMC article.
Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer.
Alyce S Adams, Jeanne M Madden, +7 authors, Jennifer J Griggs.
Value Health, 2017 Dec 16; 20(10). PMID: 29241894    Free PMC article.
A review of cancer outcomes among persons dually enrolled in Medicare and Medicaid.
Steven S Coughlin, Lee Caplan, Lufei Young.
J Hosp Manag Health Policy, 2018 Aug 14; 2. PMID: 30101216    Free PMC article.
Care experiences among dually enrolled older adults with cancer: SEER-CAHPS, 2005-2013.
Lisa M Lines, Julia Cohen, +2 authors, Erin E Kent.
Cancer Causes Control, 2019 Aug 20; 30(10). PMID: 31422490    Free PMC article.
Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults.
Jenny S Guadamuz, Katharine Ozenberger, +9 authors, Gregory S Calip.
Medicine (Baltimore), 2019 Nov 15; 98(46). PMID: 31725657    Free PMC article.
First-line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)-Medicare population-based study.
Angie Mae Rodday, Theresa Hahn, +4 authors, Susan K Parsons.
Br J Haematol, 2020 Feb 25; 190(2). PMID: 32090325    Free PMC article.
Disparities in Access to Sorafenib in Communities with Low Socioeconomic Status.
Umut Sarpel, Marina Heskel, +3 authors, Francesca Gany.
J Health Care Poor Underserved, 2018 Aug 21; 29(3). PMID: 30122687    Free PMC article.
Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants.
Jennifer L Moss, Jeanne Murphy, +3 authors, Sarah M Temkin.
Support Care Cancer, 2018 Jul 14; 27(2). PMID: 30003341    Free PMC article.